FMC / Immune Defic / M. (1995) J. / Amersham / S. (1995) J. / Becton Dickinson / DuPont / Walsh S. P. / Proudfoot A. E. / Fauci A. S. / Khan S. A. / /
Country
Germany / Italy / United States / Columbia / / /
Event
M&A / Product Issues / /
Facility
Biolog Life Sciences Institute / Institute of Human Virology / University of Maryland Biotechnology Institute / University of Chieti / Institute of Normal Human Morphology / Intracellular cAMP Level / University of Ferrara / /
IndustryTerm
treatment of depression / treatment of HIV / expected amplification products / /
MedicalCondition
productive infection / HIV / HIV infection / Cancer / disease / AIDS / infection / productive HIV infection / depression / /
MedicalTreatment
vaccination / chemotherapy / /
Movie
A. D. / /
Organization
University of Chieti / Biolog Life Sciences Institute / University of Ferrara / Department of Morphology and Embryology / Institute of Normal Human Morphology / University of Maryland Biotechnology Institute / Institute of Human Virology / Ministry of Health / /
Person
Carr / Friedman / Giorgio Zauli / Prisco Mirandola / Wang / Nat / Robert C. Gallo / Sabrina Curreli / Silvano Capitani / Rosa / V / Paola Secchiero / /
Position
D. J. / Results representative / RT / Cao / representative / /
Product
IL-2 uptake / /
ProvinceOrState
Maryland / South Carolina / S. K. / M. B. / A. B. / /
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4؉ T cell hyperactivation and HIV type 1 replication